Login / Signup

Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma.

Heba MorobeidCarmen PizarroLeonie BienerGudrun Ulrich-MerzenichDaniel KüttingGeorg NickenigDirk Skowasch
Published in: ERJ open research (2021)
Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic obstructive pulmonary disease
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • smoking cessation
  • combination therapy